The prevalence of anaemia passed from 64.8% to 51.8% (p<0.001) and the mean of Hb from 10.74± 1.5g/dl to 11.26±1.3g/dl (p<0.001) after treatment (Table 1). Here, GSTM1 is linked to anemia (phenotype).